Osimertinib by AstraZeneca which costs around ₹2 lakhs per dose can be bought for ₹4,500 per dose in the grey market. As many as 100-120 patients are consuming copies of Osimertinib/Afatinib.
Results that may be inaccessible to you are currently showing.